Cravath’s New York Office Moves to Two Manhattan West
On December 16, 2022, Global Investigations Review (“GIR”) published a profile of Cravath’s investigations practice in connection with the Firm’s inclusion in the “GIR 100”, a global guide to the world’s leading cross‑border investigations practices. The profile highlights the Firm’s experience with cross‑border cases, including recent representation of multi‑national pharmaceutical company Novartis and Swedish telecoms company Telia. GIR described Cravath partners Rachel G. Skaistis, John D. Buretta, Benjamin Gruenstein, David M. Stuart and Evan Norris as “top‑tier lawyers” in the space and noted the success of partners John W. White, Evan R. Chesler and Peter T. Barbur on client matters including FCPA, SEC and criminal investigations.
Deals & Cases
September 26, 2022
On September 13, 2022, Judge Kimba M. Wood of the United States District Court for the Southern District of New York ruled in favor of Cravath client Novartis, dismissing with prejudice a third amended complaint filed by Relator Steven M. Camburn. In the complaint, Relator asserted claims under the False Claims Act and analogous state laws based on Novartis’s promotion of the multiple sclerosis drug Gilenya.
Deals & Cases
Cravath Leads FCPA Resolution with DOJ and SEC; Coordinates with International Counsel Team to Conclude Investigations Worldwide
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.